Page 4 - Key Updates News Today

Congratulations to all advisers with December 31 fiscal year ends – you have emerged from another annual ADV “season”, as we affectionately call it! Welcome to our...

Centering discussion on metastatic hormone-sensitive prostate cancer (mHSPC), key opinion leaders identify core goals of treatment.

A focused review of patient and disease factors that inform selection of therapy for patients with metastatic hormone-sensitive prostate cancer.

Adobe is set to release new editing features incorporating AI technology into its Premiere Pro and After Effects software to improve post-production workflows and the efficiency of video editors.

During an OncLive® workshop titled Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice, moderated by Naval Daver, MD, faculty reviewed updates to the classification of acute myeloid leukemia and its effects on the treatment paradigm and provided insight on the management of adverse-risk and secondary acute myeloid leukemia.

Experts on non-metastatic castration-resistant prostate cancer share insight on patient monitoring strategies to improve outcomes.

Before shifting focus away from non-metastatic castration-resistant prostate cancer, medical oncologists reflect on means to optimize care and look to future directions in the field.

Delhi has witnessed an increase in the number of fresh Covid cases over the last few days amid a sharp rise in the figure of H3N2 influenza cases in the country. -- aaa

A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.

Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.